Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets

Journal of Clinical Virology

Volumn 45, Issue SUPPL. 1, 2009, Pages

  Getman, Damon ^a   Aiyer, Aparna ^a   Dockter, Janel ^a   Giachetti, Cristina ^a   Zhang, Fan ^b   Ginocchio, Christine C ^b  

^a Gen Probe Incorporated   (United States)

^b Department of Laboratory Medicine ^*  (United States)

Author keywords

APTIMA ; Cervical cancer; Cytology; HPV; Molecular diagnostics; RNA testing

Indexed keywords

DNA; GENOMIC DNA; PLASMID VECTOR; RNA; MESSENGER RNA; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; IN VITRO STUDY; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; PAPILLOMA VIRUS; PRIORITY JOURNAL; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADULT; AGED; ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; EVALUATION; GENETICS; MIDDLE AGED; REPRODUCIBILITY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 67949097553     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(09)70008-3     Document Type: Article

References (13)

1. Szarewski A., Ambroisine L., Cadman L., Austin J., Ho L., Terry G., et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 17 (2008) 3033-3042
2. Monsonego J., Bohbot J.M., Pollini G., Krawec C., Vincent C., Merignargues I., et al. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol 99 (2005) 160-168
3. Sandri M.T., Lentati P., Benini E., Dell'Orto P., Zorzino L., Carozzi F.M., et al. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 44 (2006) 2141-2146
4. Carozzi F., Bisanzi S., Sani C., Zappa M., Cecchini S., Ciatto S., et al. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease. J Clin Microbiol 45 (2007) 364-369
5. De Francesco M.A., Gargiulo F., Schreiber C., Ciravolo G., Salinaro F., and Manca N. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear. J Virol Methods 147 (2008) 10-17
6. Stevens M.P., Garland S.M., Rudland E., Tan J., Quinn M.A., and Tabrizi S.N. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 45 (2007) 2130-2137
7. Wahlström C., Iftner T., Dillner J., Dillner L., and Swedescreen study group. Population-based study of screening test performance indices of three human papillomavirus DNA tests. J Med Virol 79 (2007) 1169-1175
8. Pett M., and Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis. J Pathol 212 (2007) 356-367
9. Gen-Probe APTIMA HPV Assay [package insert]. Gen-Probe Inc., San Diego, CA, USA; 2008.
10. Baker C., Phelps W., Lindgren V., Braun M., Gonda M., and Howley P. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61 (1987) 962-971
11. Yee C., Krishnan-Hewlett I., Baker C., Schlegel R., and Howley P. Presence and expression of human papillomavirus sequences in human cervical cancer cell lines. Am J Pathol 119 (1985) 361-366
12. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J Clin Virol 32 (2005) S16-S24
13. Cuzick J., Clavel C., Petry K., Meijer C., Hoyer H., Ratnam S., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119 (2006) 1095-1101